-
p-Aminosalicylic Acid Buyers List
p-Aminosalicylic acid (PAS) is an antibiotic used to treat tuberculosis. It is also used to treat other infections, such as leprosy and schistosomiasis. PAS is available as a tablet, capsule, or suspension. The global market for p-Aminosalicylic acid is expected to grow at a CAGR of 3.5% from 2022 to 2028. This growth is being driven by the increasing prevalence of tuberculosis, the rising demand for generic drugs, and the increasing number of clinical trials for PAS. The main buyers of p-Aminosalicylic acid are pharmaceutical companies, hospitals, clinics, and research institutes. The pharmaceutical companies are the major buyers of PAS, as they use it to manufacture their own products. Hospitals…
-
Pyrantel Global Buyers List
Pyrantel is a medication used to treat parasitic infections caused by roundworms, pinworms, and whipworms. It is available as a tablet, capsule, or suspension. The global market for Pyrantel is expected to grow at a CAGR of 4.5% from 2022 to 2028. This growth is being driven by the increasing prevalence of parasitic infections, the rising demand for generic drugs, and the increasing number of clinical trials for Pyrantel. The main buyers of Pyrantel are pharmaceutical companies, hospitals, clinics, and research institutes. The pharmaceutical companies are the major buyers of Pyrantel, as they use it to manufacture their own products. Hospitals and clinics also purchase Pyrantel in large quantities, as…
-
Ticagrelor Global Buyers List
Ticagrelor is a drug used to prevent blood clots in people with acute coronary syndrome (ACS) and unstable angina. It is also used to prevent heart attack and stroke in people with a history of these conditions. Ticagrelor is a member of the thienopyridine class of drugs, which also includes clopidogrel and prasugrel. The global market for Ticagrelor is expected to grow at a CAGR of 8.47% from 2022 to 2028. This growth is being driven by the increasing prevalence of cardiovascular diseases, the rising demand for effective antiplatelet drugs, and the increasing number of clinical trials for Ticagrelor. The main buyers of Ticagrelor are pharmaceutical companies, hospitals, clinics, and…
